You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CUE Award Disclosure
Lin Shao-lee · SEC Form 4 · Filed Jul 30, 2026
Award
Reported value range
Not reported
Lin Shao-lee Chief Executive Officer
CUE
Cue Biopharma
CUE
Transaction date
Jun 1, 2026
Public filing date
Jul 30, 2026
Filing lag
Filed 59 days later
CUE daily price context
Close on/before transaction
$24.07
Jun 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Common Stock Warrants (Right to Buy) on Common Stock
- Quantity / price
- 45,453 shares
- SEC ownership
- Indirect
- Transaction code
- A
- Form
- 4/A
- Filing identifier
- 0001725092-26-000009
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$999.97K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cue Biopharma, Inc. CUE Current | Award | Jun 1, 2026 | Not reported |
| Cue Biopharma, Inc. CUE | Award | Jun 1, 2026 | $999.97K |